PATENT CLAIM ANALYSIS

Application Number: 15957457
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "131100"]

Abstract:
The aspects disclosed herein describe methods of identifying a subject that is non-responsive to anti-TNF therapy. The aspects disclosed herein further provide for a method of selecting a therapy for a subject with Inflammatory Bowel Disease (IBD), and treating the subject with the therapy.

Claim (Index 14):
The method of  claim 12 , wherein the inflammatory disease or condition, or fibrostenotic and/or fibrotic disease, comprises inflammatory bowel disease (IBD), Crohn's disease (CD), perianal Crohn's disease (pCD), ulcerative colitis (UC), rheumatoid arthritis, multiple sclerosis, psoriasis, chronic colitis, pancreatitis, leukopenia, colonic fibrosis, primary sclerosing cholangitis, progressive systemic sclerosis, chronic asthma, or fibrostenosis of a small and/or large intestine, or a combination thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.48485
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13840779', '12851517', '15030790', '13322863', '15571734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6860494060925689
- 35 USC 102 Novelty (BERT): 0.4984000636407382
- Combined Prediction Score: 0.6672844718473858
- Mean Citation Score: 146.174042
- Max Citation Score: 165.7468
- Similarity Product: 100.9121832404852

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test